Ex Parte Seseke-Koyro et al - Page 3

                Appeal 2007-0501                                                                             
                Application 10/747,956                                                                       

                claims 8 through 11 as unpatentable over Seseke-Koyro ‘641 or Lauzon,                        
                either in view of Popoola (Answer 3-4); and                                                  
                claim 12 as unpatentable over Seseke-Koyro ‘641 or Lauzon in view of                         
                Shimajiri (id. 4-5).                                                                         
                      We have relied on US 6,432,221 to Seseke-Koyro (Seseke-Koyro                           
                ‘221) of record as a translation of Seseke-Koyro ‘641 because Appellants                     
                state Seseke-Koyro ‘641 “is equivalent to” Seseke-Koyro ‘221 (Br.2 4;     see                
                also Reply Br. 1:26).  Indeed, the Examiner refers to Seseke-Koyro ‘221 in                   
                the Answer (Answer, e.g., 7:5).3                                                             
                      Appellants argue the appealed claims as a group as well as argue                       
                claims 8, 10, 11, and 12 individually, with claim 9 standing or falling with                 
                claim 8 (Br. 6, 7, 8, and 10-12).  Thus, we decide this appeal based on                      
                appealed claims 8, 10, 11, and 12 as representative of the grounds of                        
                rejection and Appellants’ groupings of claims.  37 C.F.R. § 41.37(c)(1)(vii)                 
                (2005).                                                                                      
                      The Examiner contends Seseke-Koyro ‘221 and Lauzon disclose                            
                potassium fluorozincate as a fluxing agent for aluminum brazing (Answer                      
                3 and 4).  The Examiner concludes this is a disclosure of substantially                      
                similar products to that claimed sufficient to render product-by-process                     
                claims 8, 10, and 11 prima facie obvious (id.).  With respect to these claims,               
                the Examiner further contends Seseke-Koyro ‘221 and Lauzon do not                            
                disclose the particle size of the potassium fluorozincate (id. 4).  The                      
                Examiner contends Popoola discloses a flux containing fluoride salts for                     
                brazing aluminum which is applied as a solution by spraying, wherein the                     
                                                                                                            
                2  We consider the Brief filed March 21, 2006.                                               


                                                     3                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next

Last modified: September 9, 2013